Bilobalide promotes expression of glial cell line-derived neurotrophic factor and vascular endothelial growth factor in rat astrocytes

Acta Pharmacologica Sinica

Volumn 21, Issue 2, 2000, Pages 151-155

  Zheng, Shi Xi ^a   Zhou, Li Jun ^a   Chen, Zhong Liang ^a   Yin, Meng Long ^a   Zhu, Xing Zu ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Astrocytes; Bilobalide; Ginkgo biloba; Immunohistochemistry; Neurotrophin; Reverse transcriptase polymerase chain reaction; Up regulation (physiology)

Indexed keywords

BILOBALIDE; MESSENGER RNA; NEUROTROPHIC FACTOR; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; DRUG STRUCTURE; GLIA CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT;

ANIMALS; ASTROCYTES; CELL LINE; CYCLOPENTANES; DITERPENES; ENDOTHELIAL GROWTH FACTORS; FURANS; GINKGO BILOBA; GINKGOLIDES; LYMPHOKINES; NEUREGULIN-1; PLANTS, MEDICINAL; RATS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034141361     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Maurer K, Ihl R, Dierks T, Frolich L. Clinical efficacy of Ginkgo biloba special extract GbE 761 in dementia of the Alzheimer type. J Psychiatr Res 1997; 31: 645-55.
2. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. J Am Med Assoc 1997; 278: 1327-32.
3. Tighilet B, Lacour M. Pharmacological activity of the Ginkgo biloba extract (GbE 761) on equilibrium function recovery in the unilateral vestibular neurectomized cat. J Vestib Res 1995; 5: 187-200.
4. Song W, Zhu XZ. Up-regualtion of LPS-induced iNOS activity in dibutyryl cyclic AMP-differentiated rat astrocytes. Acta Pharmacol Sin 1998; 19; 462-6.
5. Eddleston M, Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 1993; 54: 15-36.
6. Kokaia Z, Zhao Q, Kokaia M, Elmer E, Metsis M, Smith ML, et al. Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Exp Neurol 1995; 136: 73-88.
7. Bruno C, Cuppini R, Sartini S, Cecchini T, Ambrogini P, Bombardelli E. Regeneration of motor nerves in bilobalide-treated rats. Planta Med 1993; 59: 302-7.
8. Lin LH, Doherty DH, Lile JD, BeKtesh S, Collins F. GDNF: a glial cell line derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 130-2.
9. Lapchak PA, Gash DM, Collins F, Hilt D, Miller PJ, Araujo DM. Pharmacological activities of GDNF: Preclinical development and application to the treatment of Parkinson's disease. Exp Neurol 1997; 145: 309-21.
10. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991; 47: 211-8.
11. Rosenstein JM, Mani N, Silverman WF, Krum JM. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95: 7086-91.
12. Papavassiliou E, Gogate N, Proescholdt M, Heiss JD, Walbridge S, Edwards NA, et al. Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J Neurosci Res 1997; 49: 451-60.